Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh, Emilie Battivelli, Eric Verdin
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 407-421
Open Access | Times Cited: 203

Showing 26-50 of 203 citing articles:

Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+T Cells
Abena K. Kwaa, Chloe Adrienna Talana, Joel N. Blankson
Journal of Virology (2018) Vol. 93, Iss. 3
Open Access | Times Cited: 47
Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders
Akhil Katuri, Joseph Bryant, Alonso Heredia, et al.
Experimental and Molecular Pathology (2019) Vol. 108, pp. 64-72
Closed Access | Times Cited: 47
Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery
Sai Shashank Chavali, Rachel Bonn-Breach, Joseph E. Wedekind
Journal of Biological Chemistry (2019) Vol. 294, Iss. 24, pp. 9326-9341
Open Access | Times Cited: 43
CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
Gilles Darcis, Neeltje A. Kootstra, Berend Hooibrink, et al.
Cell Reports (2020) Vol. 30, Iss. 7, pp. 2284-2296.e3
Open Access | Times Cited: 43
The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy
Erin M. B. Scholz, Angela D. M. Kashuba
Clinical Pharmacology & Therapeutics (2021) Vol. 109, Iss. 4, pp. 918-927
Open Access | Times Cited: 33
Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir
Weiwei Dai, Fengting Wu, Natalie F. McMyn, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 27
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13
Organelles – understanding noise and heterogeneity in cell biology at an intermediate scale
Amy Y. Chang, Wallace F. Marshall
Journal of Cell Science (2017) Vol. 130, Iss. 5, pp. 819-826
Open Access | Times Cited: 48
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui
Pengfei Wang, Panpan Lu, Xiying Qu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 48
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
Mateusz Stoszko, Elisa De Crignis, Casper Rokx, et al.
EBioMedicine (2015) Vol. 3, pp. 108-121
Open Access | Times Cited: 44
Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes
Xiaoli Tang, Huafei Lü, Mark S. Dooner, et al.
JCI Insight (2018) Vol. 3, Iss. 7
Open Access | Times Cited: 43
Albumin–Polymer–Drug Conjugates: Long Circulating, High Payload Drug Delivery Vehicles
Anton A. A. Smith, Kaja Zuwała, Oliver Pilgram, et al.
ACS Macro Letters (2016) Vol. 5, Iss. 10, pp. 1089-1094
Closed Access | Times Cited: 41
HIV-1 Tat and Viral Latency: What We Can Learn from Naturally Occurring Sequence Variations
Doreen Kamori, Takamasa Ueno
Frontiers in Microbiology (2017) Vol. 8
Open Access | Times Cited: 40
HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies
Kaori Asamitsu, Koh Fujinaga, Takashi Okamoto
Molecules (2018) Vol. 23, Iss. 4, pp. 933-933
Open Access | Times Cited: 40
2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph
Nicholas A. Meanwell
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 16, pp. 7311-7351
Closed Access | Times Cited: 39
Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins
Sheraz Khan, Mazhar Iqbal, Muhammad Tariq, et al.
Clinical Epigenetics (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 38
SHMT2 and the BRCC36/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy
Muyu Xu, James J. Moresco, Max W. Chang, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 5, pp. e1007071-e1007071
Open Access | Times Cited: 38
P-TEFb as A Promising Therapeutic Target
Koh Fujinaga
Molecules (2020) Vol. 25, Iss. 4, pp. 838-838
Open Access | Times Cited: 36
Nanoparticle-Based Immunoengineered Approaches for Combating HIV
Allan Bowen, Elizabeth E. Sweeney, Rohan Fernandes
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 34
TRIM22. A Multitasking Antiviral Factor
Isabel Pagani, Guido Poli, Elisa Vicenzi
Cells (2021) Vol. 10, Iss. 8, pp. 1864-1864
Open Access | Times Cited: 28
Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors
Sonia Mediouni, Shuang Lyu, Susan M. Schader, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1980-1980
Open Access | Times Cited: 19
Modulation of apoptosis and viral latency – an axis to be well understood for successful cure of human immunodeficiency virus
Uddhav Timilsina, Ritu Gaur
Journal of General Virology (2016) Vol. 97, Iss. 4, pp. 813-824
Open Access | Times Cited: 36
Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies
Omar Sued, María Inés Figueroa, Pedro Cahn
Advanced Drug Delivery Reviews (2016) Vol. 103, pp. 5-19
Closed Access | Times Cited: 34
HIV-1 Latency and Eradication: Past, Present and Future
Prasun K. Datta, Rafal Kaminski, Wenhui Hu, et al.
Current HIV Research (2016) Vol. 14, Iss. 5, pp. 431-441
Open Access | Times Cited: 32
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?
Baptiste Abbar, Marine Baron, Christine Katlama, et al.
AIDS (2019) Vol. 34, Iss. 2, pp. 167-175
Open Access | Times Cited: 31

Scroll to top